ISIN | CH0046161532 |
---|---|
Valor Number | 4616153 |
Bloomberg Global ID | UESPIIX SW |
Fund Name | UBS (CH) Institutional Fund - Equities Switzerland Passive All II I-X |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland | |
Distributor(s) |
UBS AG Basel Phone: +41 61 288 20 20 |
Asset Class | Equities |
EFC Category | Equity Switzerland |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The fund invests in equities of major Swiss companies that are included in the SPI.|The fund holds all large and mid cap stocks in proportion to the free-float market capitalisation of the reference index. It invests in a selection of small cap stocks from the index according to the criteria of market liquidity and the sector’s free-float market capitalisation.|Diversification is achieved via a mix of sectors and therefore offers the investor an optimised risk/return profile.|The investment objective is to generate a performance in line with that of the benchmark, keeping the Tracking Error below the maximum of 0.5% over a rolling period of 3 years. |
Peculiarities | In Liquidation |
Current Price * | 3,829.89 CHF | 05.06.2025 |
---|---|---|
Previous Price * | 3,821.99 CHF | 04.06.2025 |
52 Week High * | 3,914.55 CHF | 03.03.2025 |
52 Week Low * | 3,294.51 CHF | 09.04.2025 |
NAV * | 3,829.89 CHF | 05.06.2025 |
Issue Price * | 3,829.89 CHF | 05.06.2025 |
Redemption Price * | 3,829.89 CHF | 05.06.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 5,761,753,208 | |
Unit/Share Assets *** | 5,211,416,997 | |
Trading Information SIX |
YTD Performance | +9.73% |
31.12.2024 - 05.06.2025
31.12.2024 05.06.2025 |
---|---|---|
1 month | +1.90% |
05.05.2025 - 05.06.2025
05.05.2025 05.06.2025 |
3 months | -1.87% |
05.03.2025 - 05.06.2025
05.03.2025 05.06.2025 |
6 months | +8.12% |
05.12.2024 - 05.06.2025
05.12.2024 05.06.2025 |
1 year | +5.16% |
05.06.2024 - 05.06.2025
05.06.2024 05.06.2025 |
2 years | +11.93% |
05.06.2023 - 05.06.2025
05.06.2023 05.06.2025 |
3 years | +12.55% |
07.06.2022 - 05.06.2025
07.06.2022 05.06.2025 |
5 years | +30.57% |
05.06.2020 - 05.06.2025
05.06.2020 05.06.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Nestle SA | 14.47% | |
---|---|---|
Roche Holding AG | 11.91% | |
Novartis AG Registered Shares | 11.64% | |
Zurich Insurance Group AG | 5.37% | |
UBS Group AG | 4.98% | |
Compagnie Financiere Richemont SA Class A | 4.92% | |
ABB Ltd | 4.34% | |
Holcim Ltd | 3.13% | |
Swiss Re AG | 2.74% | |
Lonza Group Ltd | 2.68% | |
Last data update | 30.04.2025 |
TER | 0.00% |
---|---|
TER date | 31.10.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.00% |
Ongoing Charges *** | 0.00% |
SRRI ***
|
|
SRRI date *** | 31.05.2025 |